XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue:      
Revenues $ 266,274 $ 202,085 $ 148,616
Cost of goods sold $ 83,970 $ 64,514 $ 58,842
Cost, Product and Service [Extensible Enumeration] Product revenue, net Product revenue, net Product revenue, net
Gross profit $ 182,304 $ 137,571 $ 89,774
Operating expenses:      
Selling, general and administrative 198,025 164,944 141,840
Research and development 9,172 6,556 4,742
In-process research and development 0 8,869 2,000
Revaluation of contingent royalty obligation payable to Evolus Founders 7,176 4,257 5,755
Depreciation and amortization 2,342 2,178 767
Total operating expenses 216,715 186,804 155,104
Loss from operations (34,411) (49,233) (65,330)
Other income (expense):      
Interest income 3,263 860 119
Interest expense (18,735) (13,832) (9,097)
Other income (expense), net 127 696 (9)
Loss before income taxes: (49,756) (61,509) (74,317)
Income tax expense 664 176 95
Net loss (50,420) (61,685) (74,412)
Other comprehensive loss:      
Unrealized loss, net of tax (478) (90) (337)
Comprehensive loss $ (50,898) $ (61,775) $ (74,749)
Net loss per share, basic (in dollars per share) $ (0.81) $ (1.08) $ (1.33)
Net loss per share, diluted (in dollars per share) $ (0.81) $ (1.08) $ (1.33)
Weighted-average shares outstanding used to compute basic net loss per share (in shares) 62,016,853 56,918,721 56,065,297
Weighted-average shares outstanding used to compute diluted net loss per share (in shares) 62,016,853 56,918,721 56,065,297
Product revenue, net      
Revenue:      
Revenues $ 264,306 $ 199,721 $ 146,592
Service revenue      
Revenue:      
Revenues $ 1,968 $ 2,364 $ 2,024